D-Wave Quantum’s $20 Million University System Sale Stirs Optimism, but Revenue Slide Spurs Analyst Revisions Ahead of June Investor Day
Published on 05/14/2026 at 22:01 | Redaktion boerse-global.de
A single quarter can tell two completely different stories for D-Wave Quantum. On the one hand, the company just logged its highest-ever quarterly order intake, vaulting past $33 million on the back of a $20 million system sale to Florida Atlantic University and a major enterprise license. On the other, revenue collapsed 81 percent year-over-year to just $2.9 million, missing consensus by nearly a third. The result: a split verdict from Wall Street, where most analysts keep calling the stock a buy but several have trimmed their price targets.
The net loss for the first quarter of 2026 widened to $18.4 million from $5.4 million a year earlier, dragged by operating expenses that surged 125 percent to $56.5 million. That line item included $9.1 million in one-time costs tied to the acquisition of Quantum Circuits. Still, the per-share loss of $0.05 came in narrower than analysts had expected, providing a sliver of cover for the revenue miss.
D-Wave’s cash position remains a bulwark. The company ended the quarter with $588 million in cash and marketable securities, a 93 percent increase year-over-year. That war chest, combined with $42.4 million in remaining performance obligations — essentially contracted future revenue — gives management the breathing room to execute on its long-term road map.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The order book’s strength centers on two blockbuster deals: the Quantum Annealing system sold to Florida Atlantic University for $20 million and a separate multi-million-dollar license agreement with an unnamed corporate client. Those wins pushed total bookings to a record level and lifted the backlog well above where it stood at the end of fiscal 2025. D-Wave plans to recognize revenue from two annealing systems in fiscal 2026, including what would be its first commercial customer deployment.
Analyst reactions have been a study in nuance. Evercore ISI lowered its price target to $37 from $42, Mizuho to $29 from $31, and Canaccord Genuity to $41 from $43 — yet all three maintain buy ratings. Jefferies’ Kevin Garrigan held firm at $45, and Rosenblatt Securities kept its $43 target, also with a buy. Across the Street, 13 analysts now rate the shares a buy, with zero sells or holds. The stock traded around €18.86 at last check, up roughly 4 percent on the day but still more than 50 percent off its October 2025 high. Year-to-date it has shed over 21 percent.
Beyond the immediate numbers, D-Wave is laying out a multi-year technology trajectory. The company expects to have 175 physical qubits in its next-generation architecture by the end of 2028. A longer leap targets fault-tolerant systems: by 2032, D-Wave aims to deliver 100 logical qubits. In the nearer term, management plans to book two to three annealing systems in 2026, a pace that would gradually convert the record backlog into recognized sales.
The next major test comes in a few weeks. D-Wave will present at the J.P. Morgan conference in Boston and TD Cowen in New York before hosting its first-ever Investor Day on June 1, 2026, under the banner “The D-Wave Difference.” There, executives must show how a pipeline of orders transforms into sustainable revenue — a question that has dogged the stock even as the order book swells.
Ad
D-Wave Quantum Stock: New Analysis - 14 May
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
